Developing regions vs Mongolia: Proportion of the target population who received a 3rd dose of
Developing regions
66.0%
in 2024
Mongolia
96.0%
in 2024
Developing regions rank
12th
Mongolia rank
15th
Proportion of the target population who received a 3rd dose of over time
- Developing regions
- Mongolia
How they compare
Mongolia currently reports 96.0% against 66.0% in Developing regions, a difference of 30.0%.
That makes Mongolia's figure about 1.5 times Developing regions's.
The two have swapped places 1 time across 8 shared years of data; in 2017 it was Developing regions ahead.
Developing regions ranks 12th and Mongolia ranks 15th of 19 regions.
Across the 2 decades both report, Developing regions averaged higher in 1 and Mongolia in 1.
Head to head by decade
| Decade | Developing regions | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 44.0% | 29.3% | 14.7% | Developing regions |
| 2020s | 56.4% | 94.6% | 38.2% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Developing regions or Mongolia?
- Mongolia, at 96.0% against 66.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Developing regions and Mongolia?
- 30.0%, with Mongolia ahead.
- How many years of comparable data are there for Developing regions and Mongolia?
- 8 years are reported by both, from 2017 to 2024.
- How do Developing regions and Mongolia rank globally for proportion of the target population who received a 3rd dose of?
- Developing regions ranks 12th and Mongolia ranks 15th of 19 regions.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.